Alyeska Investment Group
ABBV icon

Alyeska Investment Group’s AbbVie ABBV Stock Holding History

Alyeska Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-762,100
Closed -$176M – 579
2025
Q3 		$176M Buy
762,100
+231,971
+44% +$47.2M 0.53% 32
2025
Q2 		$98.4M Buy
+530,129
New +$98.5M 0.35% 80
2025
Q1 		– Sell
-12,957
Closed -$2.3M – 497
2024
Q4 		$2.3M Buy
+12,957
New +$2.38M 0.01% 457
2023
Q2 		– Sell
-731,371
Closed -$117M – 529
2023
Q1 		$117M Buy
+731,371
New +$112M 1.02% 12
2020
Q2 		– Sell
-193,474
Closed -$14.7M – 466
2020
Q1 		$14.7M Sell
193,474
-370,536
-66% -$31.6M 0.29% 101
2019
Q4 		$49.9M Sell
564,010
-193,545
-26% -$16.1M 0.66% 50
2019
Q3 		$57.4M Buy
+757,555
New +$51.9M 0.83% 28
2017
Q4 		– Sell
-19,294
Closed -$1.71M – 422
2017
Q3 		$1.71M Sell
19,294
-1,752,601
-99% -$133M 0.01% 375
2017
Q2 		$128M Buy
+1,771,895
New +$119M 1.07% 9
2015
Q1 		– Sell
-13,516
Closed -$884K – 490
2014
Q4 		$884K Buy
+13,516
New +$852K 0.02% 406
2014
Q1 		– Sell
-235,000
Closed -$12.4M – 316
2013
Q4 		$12.4M Buy
+235,000
New +$11.5M 0.49% 68

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Alyeska Investment Group's ABBV Position: Q4 2025 in Review

Alyeska Investment Group sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 762,100 shares — an estimated $176M sold.

Alyeska Investment Group first reported a position in ABBV in Q4 2013 and held it in 11 quarters. The position peaked at $176M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Alyeska Investment Group reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 762,100 AbbVie shares in Q4 2025, an estimated $176M.
  • Alyeska Investment Group first reported a position in AbbVie in Q4 2013 and held it in 11 quarters.
  • Alyeska Investment Group's AbbVie position peaked at $176M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.